Hypoglycemia: Physician and Patient Perspectives

Study identifier:NIS-CUS-DUM-2010/1

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Hypoglycemia: Physician and Patient Perspectives

Medical condition

Type 2 Diabetes Mellitus

Phase

Healthy volunteers

Study drug

Sex

All

Actual Enrollment

800

Study type

Observational

Age

18 Years +

Date

Study Start Date: 01 Sept 2010

Primary Completion Date: 01 Dec 2010

Study Completion Date: 01 Dec 2010

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Jan 2015 by AstraZeneca Pharmaceuticals

Collaborators

BMS

Inclusion and exclusion criteria

No locations available

Arms	Assigned Interventions
SU T2DM patients with a prescription for a sulfonylurea but no insulin	-
Antidiabetic without SU T2DM patients with an oral antidiabetic drug other than an SU, and no insulin	-
Insulin T2DM patients using insulin, with or without other oral antidiabetics	-

"There is no result for the study"

Documents available

NIS-CUS-DUM-2010/1 CSR Synopsis
Download
Trial Results Summaries
Available here

Contacts

Contact

AstraZeneca Clinical Study Information

800-236-9933

information.center@astrazeneca.com

Investigators

Principal Investigator

Setareh Williams

AstraZeneca

Hypoglycemia: Physician and Patient Perspectives

Official Title

Medical condition

Phase

Healthy volunteers

Study drug

Sex

Actual Enrollment

Study type

Age

Date

Study design

Verification:

Sponsors

Collaborators

Inclusion Criteria

Exclusion Criteria

Documents available

NIS-CUS-DUM-2010/1 CSR Synopsis

Trial Results Summaries

Contacts

Contact

Investigators

Principal Investigator